Attached files
| file | filename |
|---|---|
| EX-10.37 - EXHIBIT 10.37 - PHASERX, INC. | v437808_ex10-37.htm |
| EX-3.6 - EXHIBIT 3.6 - PHASERX, INC. | v437808_ex3-6.htm |
| EX-4.1 - EXHIBIT 4.1 - PHASERX, INC. | v437808_ex4-1.htm |
| EX-5.1 - EXHIBIT 5.1 - PHASERX, INC. | v437808_ex5-1.htm |
| EX-1.1 - EXHIBIRT 1.1 - PHASERX, INC. | v437808_ex1-1.htm |
| EX-3.3 - EXHIBIT 3.3 - PHASERX, INC. | v437808_ex3-3.htm |
| EX-3.5 - EXHIBIT 3.5 - PHASERX, INC. | v437808_ex3-5.htm |
| S-1/A - S-1/A - PHASERX, INC. | v437808_s1a.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the inclusion in Amendment No. 1 to the Registration Statement on Form S-1 (File No. 333-210811) of PhaseRx, Inc. of our report dated February 12, 2016, except as to Note 13, as to which the date is May 2, 2016, on our audits of the balance sheets of PhaseRx, Inc. ("the Company") as of December 31, 2015 and 2014, and the related statements of operations, stockholders' deficit, and cash flows for the years then ended. We also consent to the reference to us under the heading "Experts" in the Registration Statement.
Our report dated February 12, 2016, except as to Note 13, as to which the date is May 2, 2016, contains an explanatory paragraph that states that the financial statements have been prepared assuming the Company will continue as a going concern. The Company has recurring operating losses and negative cash flows from operations. These conditions raise substantial doubt about the Company's ability to continue as a going concern.
/S/ PETERSON SULLIVAN LLP
Seattle, Washington
May 2, 2016